The global organ preservation market size was valued at USD 308.32 million in 2025 and is projected to grow from USD 324.66 million in 2026 to USD 490.75 million by 2034, registering a CAGR of 5.3% during the forecast period from 2026 to 2034. North America dominated the organ preservation market with a market share of 39.2% in 2025.
Organ preservation refers to the techniques and processes used to maintain the viability and function of organs outside the body for transplantation purposes. It is a critical component of organ transplantation, ensuring that organs remain in optimal condition during the time between donation and transplantation. Various methods of preservation, such as cold storage, hypothermic perfusion, and machine perfusion, help slow down metabolic processes, reduce cell damage, and extend the time an organ can be safely stored.
Download a Free Sample To learn more about this report,
Growing Adoption of Normothermic Machine Perfusion for Donor Organ Assessment
The organ preservation market is shifting from relying primarily on static cold storage toward machine perfusion technologies that maintain organs under more physiologically supportive conditions. Normothermic machine perfusion circulates warm, oxygenated, nutrient-rich fluid through donor organs, allowing transplant teams to evaluate organ function before transplantation. This approach is particularly valuable for marginal or extended-criteria donor organs that might otherwise be considered unsuitable for transplantation.
Machine perfusion can also provide transplant teams with additional time for organ assessment, transportation, and surgical planning. As transplant centers seek to improve utilization of available donor organs, real-time functional assessment is becoming increasingly important.
The development demonstrates how advanced perfusion technologies are expanding beyond conventional preservation toward organ assessment and emerging transplant applications.
Shift Toward Vitrification and Nanowarming for Extended Organ Storage
Another important organ preservation market trend is research into vitrification and nanowarming technologies capable of overcoming the short preservation windows associated with conventional storage. Vitrification rapidly cools biological tissue into a glass-like state while minimizing damaging ice-crystal formation. Nanowarming can then provide rapid and relatively uniform rewarming, helping address one of the major technical barriers associated with cryopreserving large biological tissues and organs.
Successful development of these technologies could eventually separate organ recovery from immediate transplantation, providing considerably greater flexibility for matching, transportation, preparation, and surgical scheduling.
Continued advances in cryopreservation could therefore fundamentally change how donor organs are stored and transported over longer periods.
Growing Burden of End-Stage Organ Disease and Transplant Requirements
The increasing burden of kidney, liver, heart, and lung failure is supporting organ preservation market growth by maintaining strong requirements for transplantation. Chronic kidney disease, cardiovascular disorders, diabetes, liver disease, and other long-term conditions can eventually progress to irreversible organ damage, leaving transplantation as an important treatment option for eligible patients.
Preservation technologies are essential because donor organs must remain viable between procurement and implantation. Improvements that extend preservation time or allow clinicians to assess previously marginal organs can potentially increase the proportion of recovered organs ultimately used for transplantation.
Continued transplantation requirements are strengthening organ preservation market demand for solutions capable of protecting organ quality and supporting greater donor-organ utilization.
Limited Availability of Suitable Donor Organs
The shortage of transplantable organs remains an important structural restraint because preservation technologies can only be used when suitable donor organs become available. Many potential organs are never recovered or transplanted because of donor suitability, organ condition, transportation constraints, ischemic injury, recipient matching, or logistical limitations.
The problem can be particularly significant for organs with relatively short preservation windows. Geographic separation between donors and recipients can further complicate allocation and transportation, potentially influencing the organ preservation market size by limiting the number of transplant procedures that can ultimately be performed.
Increasing donor registration, improving organ-recovery practices, and reducing avoidable organ non-use remain important for expanding transplantation activity.
Expansion of Organ Preservation Infrastructure and Specialized Transplant Logistics
Increasing transplant activity is creating opportunities for specialized organ-care centers, transportation networks, monitoring technologies, and centralized preservation services. Instead of requiring every donor organ to move immediately from procurement to the recipient hospital, dedicated infrastructure can potentially provide controlled preservation, assessment, and logistics support.
Such systems could improve coordination between organ procurement organizations and transplant centers while allowing preservation technologies to be deployed more efficiently. Centralized infrastructure could be particularly valuable as transplantation increasingly involves organs traveling longer distances.
Companies combining preservation equipment, monitoring, transportation, and clinical logistics have opportunities to strengthen their organ preservation market share as transplantation networks become more technologically coordinated.
Maintaining Organ Viability During Transportation and Time-Sensitive Logistics
The organ preservation industry faces the continuing challenge of safely transporting donor organs within strict clinical timeframes. Organ recovery can occur hundreds or thousands of kilometers from the recipient hospital, requiring coordination among procurement teams, transplant centers, couriers, airlines, ground transportation providers, laboratories, and surgical teams.
Unexpected transportation delays, temperature deviations, equipment problems, weather disruptions, or scheduling changes can reduce the usable preservation window. The challenge is especially significant because organ quality can deteriorate progressively during ischemic storage.
Improving real-time tracking, temperature control, transportation reliability, and communication between transplant stakeholders will remain essential for reducing logistical risk and ensuring that recovered organs reach recipients in transplantable condition.
University of Wisconsin (UW) Solution Dominated the Market with 42.3% Share in 2025
The University of Wisconsin (UW) solution segment accounted for the largest share of the global organ preservation market at 42.3% in 2025, driven by its proven effectiveness in preserving abdominal organs, widespread clinical acceptance, and extensive use in kidney, liver, and pancreas transplantation procedures. Its ability to minimize ischemic injury and improve transplant outcomes has reinforced its leading market position.
Request Customizationto receive a tailored report.
Lung is Expected to be the Fastest-Growing Segment with a CAGR of 8.7%
The lung segment is anticipated to witness the fastest growth, registering a CAGR of 8.7% during 2026–2034, fueled by the increasing prevalence of end-stage pulmonary diseases, rising lung transplant procedures, and advancements in ex vivo lung perfusion (EVLP) technologies that improve donor organ utilization and transplantation success rates.
Static Cold Storage Dominated the Market with 56.2% Share in 2025
The static cold storage segment held the largest market share of 56.2% in 2025, owing to its cost-effectiveness, ease of implementation, and widespread adoption as the standard preservation technique for solid organ transplantation. Its reliability in maintaining organ viability during transport continues to support its dominance across transplant centers worldwide.
Speak to an Analystto discuss market opportunities.
North America dominated the global organ preservation market with a 39.2% market share, valued at USD 120.86 million in 2025. The region's leadership is supported by a well-established transplant infrastructure, increasing organ donation and transplantation procedures, favorable reimbursement frameworks, and widespread adoption of advanced organ preservation technologies, including machine perfusion systems. Continuous investments in transplant research and healthcare innovation further strengthen market growth.
The United States accounted for an estimated USD 106.36 million of the market in 2025, making it the largest contributor in North America. Market growth is driven by the rising number of organ transplant procedures, strong presence of leading organ preservation technology providers, increasing adoption of normothermic and hypothermic machine perfusion systems, and significant government and institutional funding for transplant research.
Canada generated an estimated USD 14.50 million in 2025. Growing investments in transplant infrastructure, increasing awareness of organ donation, expanding adoption of advanced preservation technologies, and supportive public healthcare initiatives are contributing to the country's market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific accounted for 22.4% of the global organ preservation market, valued at USD 69.06 million in 2025, and is projected to register the fastest CAGR of 9.3% during the forecast period. Rising healthcare expenditure, growing incidence of end-stage organ diseases, expanding transplant infrastructure, and increasing government initiatives to strengthen organ donation programs are accelerating regional market growth.
China accounted for an estimated USD 29.01 million in 2025, making it the largest market in Asia Pacific. Market growth is driven by healthcare reforms, increasing investments in transplant centers, expansion of organ donation programs, and growing adoption of advanced organ preservation and machine perfusion technologies.
Japan generated an estimated USD 15.19 million in 2025. The country's aging population, increasing prevalence of chronic kidney and liver diseases, technological advancements in transplantation, and strong focus on clinical innovation continue to support demand for organ preservation solutions.
Europe accounted for 28.1% of the global organ preservation market share, reaching USD 86.64 million in 2025. The regional market is supported by robust public healthcare systems, increasing organ transplantation activities, favorable regulatory frameworks, and ongoing investments in research related to machine perfusion and organ preservation technologies. Collaborative initiatives among European transplant networks further enhance organ utilization rates.
Germany led the European market with an estimated value of USD 18.19 million in 2025. The country's advanced healthcare infrastructure, high transplant volumes, strong medical device manufacturing sector, and continuous investment in clinical research are driving the adoption of innovative organ preservation solutions.
The United Kingdom represented an estimated USD 13.86 million in 2025. Growth is supported by NHS investments in transplantation services, increasing organ donation awareness campaigns, expanding use of ex vivo organ perfusion technologies, and ongoing research to improve transplant outcomes.
The Middle East & Africa accounted for 4.2% of the global organ preservation market, totaling USD 12.95 million in 2025. Market growth is supported by expanding healthcare infrastructure, increasing investments in organ transplant programs, improving access to specialized healthcare services, and rising awareness regarding organ donation across the region.
The United Arab Emirates (UAE) accounted for an estimated USD 3.24 million in 2025. The country's market is driven by investments in advanced healthcare infrastructure, establishment of specialized transplant centers, government initiatives to promote organ donation, and increasing adoption of innovative organ preservation technologies.
Africa is witnessing gradual growth in the organ preservation market, supported by improving healthcare infrastructure, increasing awareness of organ donation, and expanding transplant capabilities. Countries such as South Africa, Kenya, and Egypt are investing in transplant programs and healthcare modernization, creating long-term opportunities for manufacturers of organ preservation solutions.
The global organ preservation industry is moderately fragmented in nature due to the presence of established medical technology companies and specialized transplant solution providers competing across static cold storage, hypothermic machine perfusion, and normothermic machine perfusion technologies. The top players in the industry are XVIVO, TransMedics, Inc., 21st Century Medicine, Bridge to Life Ltd., Preservation Solutions, Inc., Global Transplant Solutions, Organ Recovery Systems, Artivion, Inc., Getinge, Franz Köhler Chemie GmbH, Essential Pharmaceuticals, LLC, OrganOx Limited, Waters Medical Systems, LLC, Carnamedica, Vascular Perfusion Solutions, Inc., and others.
The industry participants are inclined towards product innovation to extend organ preservation times, improve donor organ viability, increase organ utilization, and enhance transplant outcomes. Companies are increasingly focusing on normothermic and hypothermic machine perfusion, real-time organ assessment, controlled-temperature transport systems, and integrated transplant logistics to support heart, lung, liver, and kidney transplantation.
TransMedics is a medical technology company specializing in organ transplant solutions through its Organ Care System (OCS). The platform maintains donor hearts, lungs, and livers in a functioning, metabolically active state outside the body while allowing clinical teams to assess organs before transplantation. The company also combines its preservation technology with transplant logistics services to support organ transportation and expand access to donor organs.
Key market players are actively adopting various business strategies to strengthen their position and drive market growth. These strategies include strategic collaborations, acquisitions, awareness programs, government initiatives, and product approvals and launches. By forming alliances with healthcare institutions, biotechnology firms, and research organizations, companies aim to accelerate innovation and expand their market reach.
Getinge is a Swedish medical technology company with expertise in healthcare and life sciences solutions. It offers products and services for intensive care, cardiovascular procedures, operating rooms, sterile processing, and life sciences. Moreover, the company specializes in enhancing clinical outcomes, optimizing hospital workflows, and improving patient care with cutting-edge medical technologies.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Transcriptomics Market Size, Share, Growth, Analysis, 2034
Paper Diagnostics Market Size, Share, Growth, Forecast, 2034
Cell Separation Technologies Market Size, Share, Growth, 2034
Immunoprotein Diagnostic Testing Market Size, Share, Growth, 2034
Point of Care Diagnostics Market Size, Share, Growth, Analysis, 2034
Intravenous Immunoglobulin Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com